GlassScriptPhysician profile
Rebecca Yang
NPI 1508119983
$1,029.24
in general payments reported to CMS, 2019-2025
22 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2021: $198 · 2022: $26.68 · 2023: $169 · 2024: $284 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $169.51 | 2021 | |
| Genzyme Corporation | $96.44 | 2023-2025 | |
| Qol Medical, LLC | $86.12 | 2019-2024 | Sucraid |
| Neuraxis, INC. | $85.17 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $69.11 | 2019 | |
| Abbvie INC. | $54.36 | 2019-2024 | |
| Alcresta Therapeutics, INC. | $51.21 | 2025 | Relizorb |
| Ironwood Pharmaceuticals, INC | $46.50 | 2024 | |
| Albireo Pharma, INC. | $45.32 | 2022-2023 | Bylvay |
| Mirum Pharmaceuticals, INC. | $36.45 | 2024-2025 | Livmarli |
| Catalyst Pharmaceuticals, INC. | $31.79 | 2024 | |
| Abbott Laboratories | $30.73 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.47 | 2024 | Eohilia |
| Travere Therapeutics, INC. | $27.60 | 2019-2021 | |
| Medtronic, INC. | $25.35 | 2024 | Endoflip |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | $25.32 | 2023 | Imcivree |
| Evoendo, INC | $23.74 | 2025 | |
| Mauna Kea Technologies, INC. | $21.70 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $21.66 | 2023 | Bylvay |
| Coloplast Corp | $20.29 | 2024 | |
| Avanos Medical | $18.11 | 2023 | Mic-Key |
| Nestle Healthcare Nutrition INC. | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.